Abstract
References
1.
Heesen C
,
Bruegmann M
,
Gbdamosi J
,
Koch E
,
Mönch A
,
Buhmann C.
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone . Mult Scler
2003 ; 9 : 213 -214 .
2.
Ghalie RG
,
Mauch E
,
Edan G
,
Hartung HP
,
Gonsette RE
,
Eisenmann S
et al.
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis . Mult Scler
2002 ; 8 : 441 -445 .
3.
Felix CA.
Secondary leukemias induced by topoisomerase-targeted drugs . Biochem Biophys Acta
1998 ; 1400 : 233 -255 .
4.
Vicari AM
,
Ciceri F
,
Folli F
,
Lanzi R
,
Colombo B
,
Comi G
et al.
Acute promyelocytic leukaemia following mitoxantrone as single agent for treatment of multiple sclerosis . Leukemia
1998 ; 12 : 441 -442 .
5.
Brassat D
,
Recher C
,
Waubant E
,
Le Page E
,
Rigal-Huguet F
,
Laurent G
et al.
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS . Neurology
2002 ; 59 : 954 -955 .
6.
Radu TD
,
Marc D
,
Herve V.
Acute myeloid leukemia (AML) induced by mitoxantrone . Mult Scler
2002 ; 8 (S1 ): S 127 -S 127 .